DR. RECKEWEG R65 PsoriasinCombination Product (PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO)


Welcome to the PulseAid listing for the DR. RECKEWEG R65 Psoriasin drug offered from PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
NON-PROPRIETARY NAME: Berberis aquifolium 4X, Hydrocotyle asiatica 4X, Arsenicum album 12X, Calcarea carbonica 30X, Graphites 12X, Natrum muriaticum 30X
SUBSTANCE NAME: MAHONIA AQUIFOLIUM WHOLE; CENTELLA ASIATICA; ARSENIC TRIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; GRAPHITE; SODIUM CHLORIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1986-06-01
END MARKETING DATE: 0000-00-00


DR. RECKEWEG R65 Psoriasin Combination Product HUMAN OTC DRUG Details:

Item DescriptionDR. RECKEWEG R65 Psoriasin Combination Product from PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
LABELER NAME: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 12; 30; 12; 30([hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL)
START MARKETING DATE: 1986-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53346-1365_cabf7ad1-d5ce-43d6-a802-24e462b7379a
PRODUCT NDC: 53346-1365
APPLICATION NUMBER:

Other MAHONIA AQUIFOLIUM WHOLE; CENTELLA ASIATICA; ARSENIC TRIOXIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; GRAPHITE; SODIUM CHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CODR. RECKEWEG R65 Psoriasin